#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal achalasia Sarcoidosis Infantile spasms Oesophageal carcinoma SAPHO syndrome Anti-HLA antibody test positive Sickle cell disease Conjunctivitis allergic Advanced systemic mastocytosis Hepatic angiosarcoma Small intestine adenocarcinoma Crigler-Najjar syndrome Dermatomyositis Synovitis Nodal marginal zone B-cell lymphoma More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Life with Disease Mantle cell lymphoma – Trials in Disease Testicular leiomyosarcoma – Trials in Disease Nodal marginal zone B-cell lymphoma – Basic Information Sjogren’s syndrome – Basic Information Arterial tortuosity syndrome – Basic Information Familial amyotrophic lateral sclerosis – Diagnostics Ornithine transcarbamoylase deficiency – Treatment Anaplastic thyroid cancer – Diagnostics Usher’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rucaparib Birtamimab VG801-1 A49 Dl-Alpha-Tocopherol Atropine Sulfate Monohydrate Arachis Hypogaea Flour Imipramine Hydrochloride Alendronic Acid Alternaria Alternata (402) Fenoterol Hydrobromide RNK001 Nirogacestat Hydrobromide Gsk3739937 Vismodegib Disodium Folinate Nazartinib Pivekimab Sunirine Desonide Sisunatovir More therapies…

    Learn about Your Condition

    Meniere's disease Peripheral artery thrombosis Myopia Vulval cancer Perineal injury Blood disorder Post cardiac arrest syndrome Cardiomyopathy Naevus flammeus Hodgkin's disease Aortic valve stenosis Palpitations Substance use disorder COVID-19 Hyperglycaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

    Recruiting

    2 1
    Investigated Drugs:
    • Iti-1284
    Bulgaria Czechia Finland Poland Slovakia

  • Study on Long-Term Safety and Effects of Maralixibat for Patients with Alagille Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Alagille syndrome
    Investigated Drugs:
    • MARALIXIBAT
    Belgium France Germany Italy The Netherlands Portugal +1

  • Study of DCC-3116 and ripretinib combination therapy in patients with advanced gastrointestinal stromal tumor (GIST)

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastrointestinal stromal tumour
    Investigated Drugs:
    • Dcc-3116
    • Ripretinib
    Denmark France Germany Greece Italy The Netherlands +2

  • Study on Colchicine to Reduce Heart Artery Inflammation in HIV Patients Over 50 with High Cardiovascular Risk

    Recruiting

    2 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Colchicine
    Spain

  • Study on the Safety and Effects of IPN01195 in Adults with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • IPN01195
    France Italy Spain

  • Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • Dexamethasone Sodium Phosphate
    • Fludarabine Phosphate
    Austria Belgium Czechia Denmark Finland France +11
Previous Page
1 … 647 648 649 650 651 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!